Name | COX-2-IN-26 |
---|
Description | COX-2-IN-26 is a potent, selective and orally active COX-2 inhibitor with IC50 values of 10.61, 0.067, 1.96 µM for COX-1, COX-2, 15-LOX, respectively. COX-2-IN-26 shows anti-inflammatory activity. COX-2-IN-26 shows gastrointestinal safety profile[1]. |
---|---|
Related Catalog | |
Target |
COX-2:0.067 μM (IC50) COX-1:10.61 μM (IC50) 15-LOX:1.96 μM (IC50) |
In Vitro | COX-2-IN-26 (compound 16) shows significant COX-2 selectivity with an SI value of 158.36[1]. |
In Vivo | COX-2-IN-26 (28 µM/kg) shows a potent anti-inflammatory activity in rats with edema inhibition relative to indomethacin of 102% and 119% in 4h and 3h, respectively[1]. .COX-2-IN-26 (10, 30, 50 mg/kg; p.o.) shows GI safety profile with normal appearance for mucosa with intact surface epithelium and preserves glands but there is some congestion of the blood vessels in albino rats[1]. |
References |
Molecular Formula | C23H21N7OS3 |
---|---|
Molecular Weight | 507.65 |